Search clinical trials for: Peginterferon Lambda-1a (BMS-914143)
Total 67 results
-
Bristol-Myers SquibbCompletedHepatitis CArgentina, Australia, Belgium, France, Germany, Italy, United States, Canada, Spain, Mexico, Austria, Poland, Netherlands, Korea, Republic of, Puerto Rico, New Zealand, Finland, Greece, Romania
-
Bristol-Myers SquibbCompletedChronic Hepatitis C Virus Infection | Chronic Hepatitis B Virus InfectionUnited States
-
Bristol-Myers SquibbCompletedHepatitis C Virus (HCV)Mexico, Korea, Republic of, Czech Republic
-
Stanford UniversityCompleted
-
Bristol-Myers SquibbCompletedHepatitis CFrance, Germany, Italy, Japan, Korea, Republic of, Russian Federation, Taiwan, United Kingdom, United States, Spain, Israel, Argentina, Poland
-
Eiger BioPharmaceuticalsCompletedHepatitis D, ChronicIsrael, New Zealand, Pakistan
-
Eiger BioPharmaceuticalsActive, not recruitingHepatitis Delta VirusUnited States, France, Belgium, Spain, Italy, Turkey, Bulgaria, Germany, Israel, Romania, Georgia, Moldova, Republic of
-
Icahn School of Medicine at Mount SinaiEiger BioPharmaceuticalsWithdrawnSARS-CoV-2
-
Bristol-Myers SquibbTerminatedChronic Hepatitis C InfectionFrance, Germany, United States, Spain, Canada, Argentina, Mexico, Belgium, Italy, Russian Federation, United Kingdom, Poland
-
Johns Hopkins UniversityEiger BioPharmaceuticalsTerminatedSars-CoV-2 InfectionUnited States
-
Bristol-Myers SquibbCompletedHepatitis B VirusAustralia, France, Germany, Korea, Republic of, Taiwan, United States, Canada, Italy, Netherlands, Singapore, Hong Kong
-
University Health Network, TorontoMichael Garron HospitalCompletedCovid-19 | Sars-CoV2Canada, Brazil
-
University Health Network, TorontoActive, not recruitingCovid19 | Sars-CoV2Canada
-
Bristol-Myers SquibbCompletedHepatitis C VirusBelgium, Germany, Spain, United States, Canada, Brazil, Austria, France, Israel, Switzerland, Italy, Russian Federation, Czechia, Poland, United Kingdom
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedHepatitis C VirusAustralia, France, United States, Spain, Italy, Netherlands, Romania, Russian Federation
-
Bristol-Myers SquibbWithdrawnHepatitis C Virus (HCV)India, Korea, Republic of, Poland, Taiwan, Spain, Canada, Russian Federation, Colombia, Singapore, Netherlands, Ireland, United Kingdom, Czech Republic, Hungary, Romania, Hong Kong, Turkey, United States, China, Egypt
-
BiogenCompleted
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Completed
-
Biosplice Therapeutics, Inc.Completed
-
Bristol-Myers SquibbCompletedHepatitis C Virus (HCV)Australia, Belgium, France, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Taiwan, United States, Chile, Hong Kong, Argentina, Netherlands, United Kingdom, Singapore, New Zealand, Finland, Greece
-
National Institute of Diabetes and Digestive and...WithdrawnChronic Hepatitis DeltaUnited States
-
Bristol-Myers SquibbTerminated
-
BiogenCompleted
-
Pontificia Universidad Catolica de ChileTelethon Kids InstituteCompletedCovid19 | SARS-CoV Infection | InterferonChile
-
BiogenCompletedMultiple Sclerosis | HealthyUnited States
-
Bristol-Myers SquibbCompletedHepatitis CFrance, Germany, Italy, Japan, United States, Australia, Puerto Rico, Spain, New Zealand
-
BiogenCompleted
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis (RRMS)Italy
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States, Italy, Switzerland, Canada, Australia, Germany, Spain, France, Portugal, Netherlands, United Kingdom, Denmark, Austria, Ireland
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Croatia, Russian Federation, India, Spain, New Zealand, Canada, Belgium, Netherlands, Bulgaria, Serbia, Greece, Ukraine, Mexico, Georgia, Colombia, Germany, Poland, United Kingdom, Czech Republic, France, Chile, Romania, Eston... and more
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Germany, Russian Federation, India, New Zealand, Spain, Belgium, Colombia, Canada, Bulgaria, Serbia, Greece, Peru, Ukraine, Poland, United Kingdom, Croatia, France, Romania, Chile, Czech Republic, Mexico, Estonia, Georgia, Latv... and more
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingSpain, Germany, Croatia, Turkey, Saudi Arabia, Hungary, Belgium, Australia, France, Portugal, Slovakia, United States, Bulgaria, Greece, Kuwait, Russian Federation, Tunisia, Italy, Argentina, Czechia, Israel, Serbia
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedHealthy Subjects | Pharmacokinetics | PharmacodynamicsUnited States
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
BiogenWithdrawnRelapsing Multiple Sclerosis
-
BiogenAMS Advanced Medical Services GmbHCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Valneva Austria GmbHRecruitingZika | Zika Virus InfectionUnited States
-
BiogenTerminatedMultiple Sclerosis, Relapsing-RemittingMexico, Turkey, United States, Hungary, Taiwan, Thailand, Korea, Republic of, Saudi Arabia, Malaysia, Colombia, Estonia, Jordan, Tunisia
-
BiogenCompletedMultiple Sclerosis | Exposure During PregnancySpain, Italy, Australia, Poland, United Kingdom, United States, Canada, France, Germany, Ireland
-
Bristol-Myers SquibbWithdrawnChronic Hepatitis C Virus Genotype 1United States
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
Bristol-Myers SquibbCompletedHepatitis C VirusAustralia, France, Mexico, United States, Canada, Germany, Denmark, Italy, Puerto Rico, Sweden, Argentina
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
BiogenCompleted
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe LtdCompleted
-
Bristol-Myers SquibbCompletedHepatitis C VirusFrance, Spain, United Kingdom, United States, Germany, Italy, Argentina, Ireland
-
Bristol-Myers SquibbWithdrawn
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted